-
1
-
-
40749150603
-
Acute lymphoblastic leukaemia
-
Pui CH, Robison LL, Look AT, (2008) Acute lymphoblastic leukaemia. Lancet 371: 1030-1043.
-
(2008)
Lancet
, vol.371
, pp. 1030-1043
-
-
Pui, C.H.1
Robison, L.L.2
Look, A.T.3
-
2
-
-
0037421590
-
Pharmacogenomics-drug disposition, drug targets, and side effects
-
Evans WE, McLeod HL, (2003) Pharmacogenomics-drug disposition, drug targets, and side effects. N Engl J Med 348: 538-549.
-
(2003)
N Engl J Med
, vol.348
, pp. 538-549
-
-
Evans, W.E.1
McLeod, H.L.2
-
3
-
-
0033966455
-
Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study
-
Pollock BH, DeBaun MR, Camitta BM, Shuster JJ, Ravindranath Y, et al. (2000) Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study. J Clin Oncol 18: 813-823.
-
(2000)
J Clin Oncol
, vol.18
, pp. 813-823
-
-
Pollock, B.H.1
DeBaun, M.R.2
Camitta, B.M.3
Shuster, J.J.4
Ravindranath, Y.5
-
4
-
-
38549100505
-
Mixed Race: Understanding Difference in the Genome Era
-
Phillips EM, Odunlami AO, Bonham VL, (2007) Mixed Race: Understanding Difference in the Genome Era. Soc Forces 86: 795-820.
-
(2007)
Soc Forces
, vol.86
, pp. 795-820
-
-
Phillips, E.M.1
Odunlami, A.O.2
Bonham, V.L.3
-
5
-
-
0038811747
-
Intensification of therapy for children with lower-risk acute lymphoblastic leukemia: long-term follow-up of patients treated on Children's Cancer Group Trial 1881
-
Hutchinson RJ, Gaynon PS, Sather H, Bertolone SJ, Cooper HA, et al. (2003) Intensification of therapy for children with lower-risk acute lymphoblastic leukemia: long-term follow-up of patients treated on Children's Cancer Group Trial 1881. J Clin Oncol 21: 1790-1797.
-
(2003)
J Clin Oncol
, vol.21
, pp. 1790-1797
-
-
Hutchinson, R.J.1
Gaynon, P.S.2
Sather, H.3
Bertolone, S.J.4
Cooper, H.A.5
-
6
-
-
0036464595
-
Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group
-
Lange BJ, Bostrom BC, Cherlow JM, Sensel MG, La MK, et al. (2002) Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood 99: 825-833.
-
(2002)
Blood
, vol.99
, pp. 825-833
-
-
Lange, B.J.1
Bostrom, B.C.2
Cherlow, J.M.3
Sensel, M.G.4
La, M.K.5
-
7
-
-
13444270315
-
Portal hypertension develops in a subset of children with standard risk acute lymphoblastic leukemia treated with oral 6-thioguanine during maintenance therapy
-
Broxson EH, Dole M, Wong R, Laya BF, Stork L, (2005) Portal hypertension develops in a subset of children with standard risk acute lymphoblastic leukemia treated with oral 6-thioguanine during maintenance therapy. Pediatr Blood Cancer 44: 226-231.
-
(2005)
Pediatr Blood Cancer
, vol.44
, pp. 226-231
-
-
Broxson, E.H.1
Dole, M.2
Wong, R.3
Laya, B.F.4
Stork, L.5
-
8
-
-
76749095066
-
Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report
-
Gaynon PS, Angiolillo AL, Carroll WL, Nachman JB, Trigg ME, et al. (2010) Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report. Leukemia 24: 285-297.
-
(2010)
Leukemia
, vol.24
, pp. 285-297
-
-
Gaynon, P.S.1
Angiolillo, A.L.2
Carroll, W.L.3
Nachman, J.B.4
Trigg, M.E.5
-
9
-
-
74349121724
-
Genetic polymorphism of inosine-triphosphate-pyrophosphatase influences mercaptopurine metabolism and toxicity during treatment of acute lymphoblastic leukemia individualized for thiopurine-S-methyl-transferase status
-
Stocco G, Crews KR, Evans WE, (2010) Genetic polymorphism of inosine-triphosphate-pyrophosphatase influences mercaptopurine metabolism and toxicity during treatment of acute lymphoblastic leukemia individualized for thiopurine-S-methyl-transferase status. Expert Opin Drug Saf 9: 23-37.
-
(2010)
Expert Opin Drug Saf
, vol.9
, pp. 23-37
-
-
Stocco, G.1
Crews, K.R.2
Evans, W.E.3
-
10
-
-
58449117037
-
Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemia
-
Stocco G, Cheok MH, Crews KR, Dervieux T, French D, et al. (2009) Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemia. Clin Pharmacol Ther 85: 164-172.
-
(2009)
Clin Pharmacol Ther
, vol.85
, pp. 164-172
-
-
Stocco, G.1
Cheok, M.H.2
Crews, K.R.3
Dervieux, T.4
French, D.5
-
11
-
-
20444419044
-
Pharmacogenetics of outcome in children with acute lymphoblastic leukemia
-
Rocha JC, Cheng C, Liu W, Kishi S, Das S, et al. (2005) Pharmacogenetics of outcome in children with acute lymphoblastic leukemia. Blood 105: 4752-4758.
-
(2005)
Blood
, vol.105
, pp. 4752-4758
-
-
Rocha, J.C.1
Cheng, C.2
Liu, W.3
Kishi, S.4
Das, S.5
-
12
-
-
35648982482
-
Pharmacogenetics of acute lymphoblastic leukemia treatment response
-
Cunningham L, Aplenc R, (2007) Pharmacogenetics of acute lymphoblastic leukemia treatment response. Expert Opin Pharmacother 8: 2519-2531.
-
(2007)
Expert Opin Pharmacother
, vol.8
, pp. 2519-2531
-
-
Cunningham, L.1
Aplenc, R.2
-
13
-
-
13144282667
-
Association of CYP3A4 genotype with treatment-related leukemia
-
Felix CA, Walker AH, Lange BJ, Williams TM, Winick NJ, et al. (1998) Association of CYP3A4 genotype with treatment-related leukemia. Proc Natl Acad Sci U S A 95: 13176-13181.
-
(1998)
Proc Natl Acad Sci U S A
, vol.95
, pp. 13176-13181
-
-
Felix, C.A.1
Walker, A.H.2
Lange, B.J.3
Williams, T.M.4
Winick, N.J.5
-
14
-
-
0033253070
-
Steroid hormone receptors: evolution, ligands, and molecular basis of biologic function
-
Whitfield GK, Jurutka PW, Haussler CA, Haussler MR, (1999) Steroid hormone receptors: evolution, ligands, and molecular basis of biologic function. J Cell Biochem Suppl 32-33: 110-122.
-
(1999)
J Cell Biochem Suppl
, vol.32-33
, pp. 110-122
-
-
Whitfield, G.K.1
Jurutka, P.W.2
Haussler, C.A.3
Haussler, M.R.4
-
15
-
-
0033135738
-
Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia
-
Relling MV, Hancock ML, Boyett JM, Pui CH, Evans WE, (1999) Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia. Blood 93: 2817-2823.
-
(1999)
Blood
, vol.93
, pp. 2817-2823
-
-
Relling, M.V.1
Hancock, M.L.2
Boyett, J.M.3
Pui, C.H.4
Evans, W.E.5
-
16
-
-
0021838288
-
The cellular pharmacology of methotrexate
-
Goldman ID, Matherly LH, (1985) The cellular pharmacology of methotrexate. Pharmacol Ther 28: 77-102.
-
(1985)
Pharmacol Ther
, vol.28
, pp. 77-102
-
-
Goldman, I.D.1
Matherly, L.H.2
-
17
-
-
0035878867
-
Pharmacogenomic dissection of resistance to thymidylate synthase inhibitors
-
Wang W, Marsh S, Cassidy J, McLeod HL, (2001) Pharmacogenomic dissection of resistance to thymidylate synthase inhibitors. Cancer Res 61: 5505-5510.
-
(2001)
Cancer Res
, vol.61
, pp. 5505-5510
-
-
Wang, W.1
Marsh, S.2
Cassidy, J.3
McLeod, H.L.4
-
18
-
-
0036143203
-
Recent insights into the mechanism of glucocorticosteroid-induced apoptosis
-
Distelhorst CW, (2002) Recent insights into the mechanism of glucocorticosteroid-induced apoptosis. Cell Death Differ 9: 6-19.
-
(2002)
Cell Death Differ
, vol.9
, pp. 6-19
-
-
Distelhorst, C.W.1
-
19
-
-
43049102346
-
TotalPlex gene amplification using bulging primers for pharmacogenetic analysis of acute lymphoblastic leukemia
-
Kang HJ, Oh Y, Chun SM, Seo YJ, Shin HY, et al. (2008) TotalPlex gene amplification using bulging primers for pharmacogenetic analysis of acute lymphoblastic leukemia. Mol Cell Probes 22: 193-200.
-
(2008)
Mol Cell Probes
, vol.22
, pp. 193-200
-
-
Kang, H.J.1
Oh, Y.2
Chun, S.M.3
Seo, Y.J.4
Shin, H.Y.5
-
20
-
-
44849117242
-
ERCC2 2251A>C genetic polymorphism was highly correlated with early relapse in high-risk stage II and stage III colorectal cancer patients: a preliminary study
-
Huang MY, Fang WY, Lee SC, Cheng TL, Wang JY, et al. (2008) ERCC2 2251A>C genetic polymorphism was highly correlated with early relapse in high-risk stage II and stage III colorectal cancer patients: a preliminary study. BMC Cancer 8: 50.
-
(2008)
BMC Cancer
, vol.8
, pp. 50
-
-
Huang, M.Y.1
Fang, W.Y.2
Lee, S.C.3
Cheng, T.L.4
Wang, J.Y.5
-
21
-
-
12144285961
-
Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase)
-
Marinaki AM, Ansari A, Duley JA, Arenas M, Sumi S, et al. (2004) Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase). Pharmacogenetics 14: 181-187.
-
(2004)
Pharmacogenetics
, vol.14
, pp. 181-187
-
-
Marinaki, A.M.1
Ansari, A.2
Duley, J.A.3
Arenas, M.4
Sumi, S.5
-
22
-
-
79956344946
-
Null genotypes of GSTM1 and GSTT1 contribute to risk of cervical neoplasia: an evidence-based meta-analysis
-
Gao LB, Pan XM, Li LJ, Liang WB, Bai P, et al. (2011) Null genotypes of GSTM1 and GSTT1 contribute to risk of cervical neoplasia: an evidence-based meta-analysis. PLoS One 6: e20157.
-
(2011)
PLoS One
, vol.6
-
-
Gao, L.B.1
Pan, X.M.2
Li, L.J.3
Liang, W.B.4
Bai, P.5
-
23
-
-
77953744553
-
Effect of CYP2D6, CYP3A5, and MDR1 genetic polymorphisms on the pharmacokinetics of risperidone and its active moiety
-
Xiang Q, Zhao X, Zhou Y, Duan JL, Cui YM, (2010) Effect of CYP2D6, CYP3A5, and MDR1 genetic polymorphisms on the pharmacokinetics of risperidone and its active moiety. J Clin Pharmacol 50: 659-666.
-
(2010)
J Clin Pharmacol
, vol.50
, pp. 659-666
-
-
Xiang, Q.1
Zhao, X.2
Zhou, Y.3
Duan, J.L.4
Cui, Y.M.5
-
24
-
-
34250326888
-
MDR1 gene polymorphisms and risk of recurrence in patients with hepatocellular carcinoma after liver transplantation
-
Wu L, Xu X, Shen J, Xie H, Yu S, et al. (2007) MDR1 gene polymorphisms and risk of recurrence in patients with hepatocellular carcinoma after liver transplantation. J Surg Oncol 96: 62-68.
-
(2007)
J Surg Oncol
, vol.96
, pp. 62-68
-
-
Wu, L.1
Xu, X.2
Shen, J.3
Xie, H.4
Yu, S.5
-
25
-
-
16844372846
-
Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia
-
Aplenc R, Thompson J, Han P, La M, Zhao H, et al. (2005) Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia. Cancer Res 65: 2482-2487.
-
(2005)
Cancer Res
, vol.65
, pp. 2482-2487
-
-
Aplenc, R.1
Thompson, J.2
Han, P.3
La, M.4
Zhao, H.5
-
26
-
-
33644840600
-
Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy
-
Cheok MH, Evans WE, (2006) Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy. Nat Rev Cancer 6: 117-129.
-
(2006)
Nat Rev Cancer
, vol.6
, pp. 117-129
-
-
Cheok, M.H.1
Evans, W.E.2
-
27
-
-
84866631524
-
Pharmacogenetic determinants of mercaptopurine disposition in children with acute lymphoblastic leukemia
-
Adam de Beaumais T, Jacqz-Aigrain E, (2012) Pharmacogenetic determinants of mercaptopurine disposition in children with acute lymphoblastic leukemia. Eur J Clin Pharmacol.
-
(2012)
Eur J Clin Pharmacol
-
-
Adam de Beaumais, T.1
Jacqz-Aigrain, E.2
-
28
-
-
20144365645
-
Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia
-
Stanulla M, Schaeffeler E, Flohr T, Cario G, Schrauder A, et al. (2005) Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia. JAMA 293: 1485-1489.
-
(2005)
JAMA
, vol.293
, pp. 1485-1489
-
-
Stanulla, M.1
Schaeffeler, E.2
Flohr, T.3
Cario, G.4
Schrauder, A.5
-
29
-
-
84860292912
-
Epistatic interactions between thiopurine methyltransferase (TPMT) and inosine triphosphate pyrophosphatase (ITPA) variations determine 6-mercaptopurine toxicity in Indian children with acute lymphoblastic leukemia
-
Dorababu P, Nagesh N, Linga VG, Gundeti S, Kutala VK, et al. (2012) Epistatic interactions between thiopurine methyltransferase (TPMT) and inosine triphosphate pyrophosphatase (ITPA) variations determine 6-mercaptopurine toxicity in Indian children with acute lymphoblastic leukemia. Eur J Clin Pharmacol 68: 379-387.
-
(2012)
Eur J Clin Pharmacol
, vol.68
, pp. 379-387
-
-
Dorababu, P.1
Nagesh, N.2
Linga, V.G.3
Gundeti, S.4
Kutala, V.K.5
-
30
-
-
0037433052
-
Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions
-
Hahn LW, Ritchie MD, Moore JH, (2003) Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 19: 376-382.
-
(2003)
Bioinformatics
, vol.19
, pp. 376-382
-
-
Hahn, L.W.1
Ritchie, M.D.2
Moore, J.H.3
-
31
-
-
0037310257
-
Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity
-
Ritchie MD, Hahn LW, Moore JH, (2003) Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity. Genet Epidemiol 24: 150-157.
-
(2003)
Genet Epidemiol
, vol.24
, pp. 150-157
-
-
Ritchie, M.D.1
Hahn, L.W.2
Moore, J.H.3
-
32
-
-
79960521621
-
Profound changes in drug metabolism enzymes and possible effects on drug therapy in neonates and children
-
de Wildt SN, (2011) Profound changes in drug metabolism enzymes and possible effects on drug therapy in neonates and children. Expert Opin Drug Metab Toxicol 7: 935-948.
-
(2011)
Expert Opin Drug Metab Toxicol
, vol.7
, pp. 935-948
-
-
de Wildt, S.N.1
-
33
-
-
2442573750
-
Phenotype and genotype for thiopurine methyltransferase activity in the French Caucasian population: impact of age
-
Ganiere-Monteil C, Medard Y, Lejus C, Bruneau B, Pineau A, et al. (2004) Phenotype and genotype for thiopurine methyltransferase activity in the French Caucasian population: impact of age. Eur J Clin Pharmacol 60: 89-96.
-
(2004)
Eur J Clin Pharmacol
, vol.60
, pp. 89-96
-
-
Ganiere-Monteil, C.1
Medard, Y.2
Lejus, C.3
Bruneau, B.4
Pineau, A.5
-
34
-
-
0142210233
-
Developmental expression of the major human hepatic CYP3A enzymes
-
Stevens JC, Hines RN, Gu C, Koukouritaki SB, Manro JR, et al. (2003) Developmental expression of the major human hepatic CYP3A enzymes. J Pharmacol Exp Ther 307: 573-582.
-
(2003)
J Pharmacol Exp Ther
, vol.307
, pp. 573-582
-
-
Stevens, J.C.1
Hines, R.N.2
Gu, C.3
Koukouritaki, S.B.4
Manro, J.R.5
-
35
-
-
80051677030
-
Genome-wide association study identified ITPA/DDRGK1 variants reflecting thrombocytopenia in pegylated interferon and ribavirin therapy for chronic hepatitis C
-
Tanaka Y, Kurosaki M, Nishida N, Sugiyama M, Matsuura K, et al. (2011) Genome-wide association study identified ITPA/DDRGK1 variants reflecting thrombocytopenia in pegylated interferon and ribavirin therapy for chronic hepatitis C. Hum Mol Genet 20: 3507-3516.
-
(2011)
Hum Mol Genet
, vol.20
, pp. 3507-3516
-
-
Tanaka, Y.1
Kurosaki, M.2
Nishida, N.3
Sugiyama, M.4
Matsuura, K.5
-
36
-
-
77952034227
-
A novel C53/LZAP-interacting protein regulates stability of C53/LZAP and DDRGK domain-containing Protein 1 (DDRGK1) and modulates NF-kappaB signaling
-
Wu J, Lei G, Mei M, Tang Y, Li H, (2010) A novel C53/LZAP-interacting protein regulates stability of C53/LZAP and DDRGK domain-containing Protein 1 (DDRGK1) and modulates NF-kappaB signaling. J Biol Chem 285: 15126-15136.
-
(2010)
J Biol Chem
, vol.285
, pp. 15126-15136
-
-
Wu, J.1
Lei, G.2
Mei, M.3
Tang, Y.4
Li, H.5
-
37
-
-
58449111231
-
The increasing complexity of mercaptopurine pharmacogenomics
-
Marsh S, Van Booven DJ, (2009) The increasing complexity of mercaptopurine pharmacogenomics. Clin Pharmacol Ther 85: 139-141.
-
(2009)
Clin Pharmacol Ther
, vol.85
, pp. 139-141
-
-
Marsh, S.1
van Booven, D.J.2
-
38
-
-
0142120075
-
Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia
-
Kadan-Lottick NS, Ness KK, Bhatia S, Gurney JG, (2003) Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia. JAMA 290: 2008-2014.
-
(2003)
JAMA
, vol.290
, pp. 2008-2014
-
-
Kadan-Lottick, N.S.1
Ness, K.K.2
Bhatia, S.3
Gurney, J.G.4
-
39
-
-
0037105454
-
Racial and ethnic differences in survival of children with acute lymphoblastic leukemia
-
Bhatia S, Sather HN, Heerema NA, Trigg ME, Gaynon PS, et al. (2002) Racial and ethnic differences in survival of children with acute lymphoblastic leukemia. Blood 100: 1957-1964.
-
(2002)
Blood
, vol.100
, pp. 1957-1964
-
-
Bhatia, S.1
Sather, H.N.2
Heerema, N.A.3
Trigg, M.E.4
Gaynon, P.S.5
|